Research Lab Results for cancer
Hsin-Chieh Yeh LabLab WebsitePrincipal Investigator:
Jessica Yeh, Ph.D.
Work in the Hsin-Chieh Yeh Lab focuses on clinical trials and cohort studies of diabetes, obesi...ty and behavioral intervention, cancer and hypertension. Recent investigations have focused on novel risk factors and complications related to obesity and type 2 diabetes, particularly lung function, smoking and cancer. We recently co-led a randomized clinical trial of tailored dietary advice for consumption of dietary supplements to lower blood pressure and improve cardiovascular disease risk factors in hypertensive urban African Americans. view moreResearch Areas: epidemiology, African Americans, cancer, obesity, hypertension, diabetes, behavioral medicine
In-vivo Cellular and Molecular Imaging CenterLab WebsitePrincipal Investigator:
Zaver Bhujwalla, Ph.D., M.Sc.
Radiology and Radiological Science
The In-vivo Cellular and Molecular Imaging Center conducts multidisciplinary research on cellul...ar and molecular imaging related to cancer. We provide resources, such as consultation on biostatistics and bioinformatics and optical imaging and probe development, to understand and effectively treat cancer. Our molecular oncology experts consult on preclinical studies, use of human tissues, interpretation of data and molecular characterization of cells and tumor tissue. view moreResearch Areas: optical imaging, molecular characterization of tumor tissue, bioinformatics, molecular oncology, biostatistics, probe development, molecular characterization of cells, cancer imaging
J. Marie Hardwick LaboratoryLab WebsitePrincipal Investigator:
J. Hardwick, Ph.D.
Pharmacology and Molecular Sciences
Our research is focused on understanding the basic mechanisms of programmed cell death in disea...se pathogenesis. Billions of cells die per day in the human body. Like cell division and differentiation, cell death is also critical for normal development and maintenance of healthy tissues. Apoptosis and other forms of cell death are required for trimming excess, expired and damaged cells. Therefore, many genetically programmed cell suicide pathways have evolved to promote long-term survival of species from yeast to humans. Defective cell death programs cause disease states. Insufficient cell death underlies human cancer and autoimmune disease, while excessive cell death underlies human neurological disorders and aging. Of particular interest to our group are the mechanisms by which Bcl-2 family proteins and other factors regulate programmed cell death, particularly in the nervous system, in cancer and in virus infections. Interestingly, cell death regulators also regulate many other cellular processes prior to a death stimulus, including neuronal activity, mitochondrial dynamics and energetics. We study these unknown mechanisms.Research Areas: cell death
We have reported that many insults can trigger cells to activate a cellular death pathway (Nature, 361:739-742, 1993), that several viruses encode proteins to block attempted cell suicide (Proc. Natl. Acad. Sci. 94: 690-694, 1997), that cellular anti-death genes can alter the pathogenesis of virus infections (Nature Med. 5:832-835, 1999) and of genetic diseases (PNAS. 97:13312-7, 2000) reflective of many human disorders. We have shown that anti-apoptotic Bcl-2 family proteins can be converted into killer molecules (Science 278:1966-8, 1997), that Bcl-2 family proteins interact with regulators of caspases and regulators of cell cycle check point activation (Molecular Cell 6:31-40, 2000). In addition, Bcl-2 family proteins have normal physiological roles in regulating mitochondrial fission/fusion and mitochondrial energetics to facilitate neuronal activity in healthy brains. view more
James Hamilton LabPrincipal Investigator:
James Hamilton, M.D.
The main research interests of the James Hamilton Lab are the molecular pathogenesis of hepatoc...ellular carcinoma and the development of molecular markers to help diagnose and manage cancer of the liver. In addition, we are investigating biomarkers for early diagnosis, prognosis and response to various treatment modalities. Results of this study will provide a molecular classification of HCC and allow us to identify targets for chemoprevention and treatment. Specifically, we extract genomic DNA and total RNA from liver tissues and use this genetic material for methylation-specific PCR (MSP), cDNA microarray, microRNA microarray and genomic DNA methylation array experiments. view moreResearch Areas: Copper homeostasis, Wilson's disease, cancer, molecular genetics, Early detection biomarker discovery for hepatocellular carcinoma, genomics, pathogenesis, liver injury, liver diseases, regulation of lipid metabolism, hepatocellular carcinoma, Pathogenesis of Liver fibrosis and cancer
Joel Pomerantz LaboratoryPrincipal Investigator:
Joel Pomerantz, Ph.D.
The Pomerantz Laboratory studies the molecular machinery used by cells to interpret extracellul...ar signals and transduce them to the nucleus to affect changes in gene expression. The accurate response to extracellular signals results in a cell's decision to proliferate, differentiate or die, and it's critical for normal development and physiology. The dysregulation of this machinery underlies the unwarranted expansion or destruction of cell numbers that occurs in human diseases like cancer, autoimmunity, hyperinflammatory states and neurodegenerative disease.Research Areas: immunology, neurodegenerative disorders, cancer, autoimmune, hyperinflammatory states, molecular biology
Current studies in the lab focus on signaling pathways that are important in innate immunity, adaptive immunity and cancer, with particular focus on pathways that regulate the activity of the pleiotropic transcription factor NF-kB. view more
Jon Russell LabPrincipal Investigator:
Jonathon Russell, M.D.
Otolaryngology - Head and Neck Surgery
The Jon Russell lab focuses on thyroid and parathyroid pathology as well as improving patient s...afety and education using healthcare technology. Additional focuses include utilizing new technology to advance on the techniques of minimally invasive neck surgery. Current and previous efforts include the development of mobile and web-based applications to educate physicians and patients, utilizing ultrasound for vocal cord imaging, understanding the nuances of advanced thyroid cancer, and exploring the role of scarless thyroid surgery in a North American population. view moreResearch Areas: patient satisfaction, thyroid cancer, perioperative information delivery, health outcomes, otolaryngology, postoperative care, endocrinology
Jun O. Liu LaboratoryLab WebsitePrincipal Investigator:
Jun Liu, Ph.D., M.S.
Pharmacology and Molecular Sciences
The Jun O. Liu Laboratory tests small molecules to see if they react in our bodies to find pote...ntial drugs to treat disease. We employ high-throughput screening to identify modulators of various cellular processes and pathways that have been implicated in human diseases from cancer to autoimmune diseases. Once biologically active inhibitors are identified, they will serve both as probes of the biological processes of interest and as leads for the development of new drugs for treating human diseases. Among the biological processes of interest are cancer cell growth and apoptosis, angiogenesis, calcium-dependent signaling pathways, eukaryotic transcription and translation. view moreResearch Areas: cancer, autoimmune, eukaryotic cells, drugs, cellular signaling, pharmacology, calcium-dependent signaling pathways, molecular biology, angiogenesis
Kathleen Gabrielson LaboratoryPrincipal Investigator:
Kathleen Gabrielson, D.V.M., Ph.D.
Molecular and Comparative Pathobiology
Research in the Kathleen Gabrielson Laboratory focuses on the signal transduction of cardiovasc...ular toxicities in vitro, in cardiomyocyte culture and in vivo using rodent models. Specifically, the research focuses on understanding the mechanisms of various cancer therapies that induce cardiac toxicities.Research Areas: cardiovascular toxicity, cancer, pathology, signal transduction
Currently, we are testing prevention strategies for these toxicities by studying the cardiac effects of the anthracycline doxorubicin (adriamycin) and the immunotherapeutic agent, Herceptin, anti-erbB2. We are focusing on the signal transduction pathways in the heart that are modulated by anti-erbB2 treatment, which in turn, worsens doxorubicin toxicity. Thus, understanding the mechanisms behind the combined toxicity of doxorubicin and anti-erbB2 will pave the way for the design of strategies to reduce toxicity, identify patients at risk and potentially allow higher levels of this effective combination therapy to be used with an improved long-term survival in patients. view more
Kathryn Carson LabPrincipal Investigator:
Kathryn Carson, Sc.M.
The Kathryn Carson Lab investigates ways to improve medical research, particularly in the areas... of brain and thyroid cancer, Alzheimer’s disease, atherosclerosis, hypertension, HIV and lupus. Our team seeks to help researchers optimize their studies through better study design, protocol and grant writing, data cleaning and analysis, and publication writing. We work with investigators from a wide range of departments through the Johns Hopkins Institute for Clinical and Translational Research. view moreResearch Areas: epidemiology, lupus, research methods, data analysis, cancer, hypertension, clinical trials, HIV, biostatistics, Alzheimer's disease
Kenneth J. Pienta LabLab WebsitePrincipal Investigator:
Kenneth Pienta, M.D.
The Kenneth J. Pienta laboratory has championed the concept that cancer tumorigenesis and metas...tasis can best be understood utilizing the principles of Ecology. As a result, the Pienta laboratory is working to develop new treatments for cancer utilizing network disruption. view moreResearch Areas: biomarkers, cancer, metastasis
Kenneth W. Kinzler LaboratoryLab WebsitePrincipal Investigator:
Kenneth Kinzler, Ph.D.
Dr. Kinzler’s laboratory has focused on the genetics of human cancer. They have identified a va...riety of genetic mutations that underlie cancer, including mutations of the APC pathway that appear to initiate the majority of colorectal cancers and IDH1/2 mutations that underlying many gliomas. In addition, they have developed a variety of powerful tools for analysis of expression and genetic alterations in cancer.Research Areas: cancer, molecular genetics
Most recently, they have pioneered integrated whole genome analyses of human cancers through expression, copy number, and mutational analyses of all the coding genes in several human cancer types including colorectal, breast, pancreatic and brain. The identification of genetic differences between normal and tumor tissues provide new therapeutic targets, new opportunities for the early diagnosis of cancer, and important insights into the neoplastic process. view more
Komatsu LabPrincipal Investigator:
Masanobu Komatsu, Ph.D.
Malfunction and malformation of blood vessels are associated with a broad range of medical cond...itions, including cancer, cardiovascular diseases, and neurological disorders. The ultimate goal of the Komatsu lab is to find a way to reverse the process of abnormal vessel formation and restore normal function to these vessels. In cancer, normalization of tumor blood vessels facilitates lymphocyte infiltration, potentiating anti-tumor immunity, and enhances the efficacy of immunotherapies as well as conventional cancer treatments. Normalization of regenerating blood vessels is also necessary for reestablishing blood flow to ischemic hearts and limbs, and preventing blindness caused by diabetic retinopathy or macular degeneration. Komatsu lab’s research is uncovering key molecular pathways important for the normalization of pathological vasculature. view moreResearch Areas: Tertiary lymphoid structure (TLS) in cancer, Drug targeting, High endothelial venules and their role in lymphocyte recruitment, Vascular normalization
Konig LabPrincipal Investigator:
Maximilian Konig, M.D.
The Konig Lab focuses on chimeric T cell- and antibody-based strategies for the treatment of au...toimmune rheumatic diseases and cancer. A primary goal of the translational research program is the development of antigen-specific and personalized immunotherapies for autoimmune diseases, with the intent to achieve sustained disease remission and functional cure. The lab further aims to establish precision T cell-targeting therapies for the treatment of various autoimmune diseases. Applying these tools to immuno-oncology, the lab utilizes cellular engineering strategies to augment the cytotoxic killing of solid cancers by the immune system. view moreResearch Areas: antigen-specific immunotherapy, myositis, autoimmunity, citrullination, rheumatology, antiphospholipid antibody syndrome, chimeric antigen receptor (CAR) T cell therapy, immuno-oncology, autoimmune rheumatic diseases, rheumatoid arthritis
Kristine Glunde LabLab WebsitePrincipal Investigator:
Kristine Glunde, Ph.D., M.S.
Radiology and Radiological Science
The Glunde lab is within the Division of Cancer Imaging Research in the Department of Radiology... and Radiological Science. The lab is developing mass spectrometry imaging as part of multimodal molecular imaging workflows to image and elucidate hypoxia-driven signaling pathways in breast cancer. They are working to further unravel the molecular basis of the aberrant choline phospholipid metabolism in cancer. The Glunde lab is developing novel optical imaging agents for multi-scale molecular imaging of lysosomes in breast tumors and discovering structural changes in Collagen I matrices and their role in breast cancer and metastasis. view moreResearch Areas: breast cancer, mass spectrometry, imaging, cancer, metastasis, metabolism, optical imaging
Lei Zheng LabLab WebsitePrincipal Investigator:
Lei Zheng, M.D., Ph.D.
Zheng’s research focuses on two R01-funded projects; first, the group has developed a pancreati...c cancer immunotherapy research program on a neoadjuvant therapy platform as well as a number of preclinical models of pancreatic cancer for developing innovative immunotherapy strategies. The group has applied the knowledge gained from pancreatic cancer immune-based therapies to the development of a colorectal cancer GVAX vaccine. Second, the group is aimed at understanding the mechanistic roles of the tumor microenvironment in cancer development and metastasis and identifying new targets for pancreatic cancer therapies by dissecting the tumor microenvironment of pancreatic cancer. view moreResearch Areas: cancer, pancreatic cancer, translational research, tumor microenvironment, immunotherapy
Linda Smith-Resar LabLab WebsitePrincipal Investigator:
Linda Smith Resar, M.D.
The Linda Smith-Resar Lab primarily investigates hematologic malignancy and molecular mechanism...s that lead to cancer as well as sickle cell anemia. Recent studies suggest that education is an important and effective component of a patient blood management program and that computerized provider order entry algorithms may serve to maintain compliance with evidence-based transfusion guidelines. Another recent study indicated that colonic epithelial cells undergo metabolic reprogramming during their evolution to colorectal cancer, and the distinct metabolites could serve as diagnostic tools or potential targets in therapy or primary prevention. view moreResearch Areas: blood disorders, sickle cell diseases, blood management programs, hematologic malignancies
Lonny Yarmus LabPrincipal Investigator:
Lonny Yarmus, D.O.
Clinical trials conducted in the Lonny Yarmus Lab focus primarily on minimally-invasive diagnos...tic testing for patients with lung cancer and local therapy options for malignant airway obstructions. We investigate ways to improve the early diagnosis of lung cancer, as well as the treatment of later-stage cancer, using the least invasive methods possible. We are also part of the LIBERATE clinical study for patients who have difficulty breathing and suffer from severe emphysema. view moreResearch Areas: emphysema, interventional pulmonology, airway stenosis, minimally-invasive diagnostic testing, lung cancer, central airway obstructions, lung transplant
Machine Biointerface LabLab WebsitePrincipal Investigator:
Gene Fridman, Ph.D., M.S.
Otolaryngology - Head and Neck Surgery
Dr. Fridman's research group invents and develops bioelectronics for Neuroengineering and Medic...al Instrumentation applications. We develop innovative medical technology and we also conduct the necessary biological studies to understand how the technology could be effective and safe for people.Research Areas: medical instruments, bioelectricities, neuroengineering, nerve stimulation
Our lab is currently focused on developing the "Safe Direct Current Stimulation" technology, or SDCS. Unlike the currently available commercial neural prosthetic devices, such as cochlear implants, pacemakers, or Parkinson's deep brain stimulators that can only excite neurons, SDCS can excite, inhibit, and even sensitize them to input. This new technology opens a door to a wide range of applications that we are currently exploring along with device development: e.g. peripheral nerve stimulation for suppressing neuropathic pain, vestibular nerve stimulation to correct balance disorders, vagal nerve stimulation to suppress an asthma attack, and a host of other neuroprosthetic applications.
Medical Instrumentation MouthLab is a "tricorder" device that we invented here in the Machine Biointerface Lab. The device currently obtains all vital signs within 60s: Pulse rate, breathing rate, temperature, blood pressure, blood oxygen saturation, electrocardiogram, and FEV1 (lung function) measurement. Because the device is in the mouth, it has access to saliva and to breath and we are focused now on expanding its capability to obtaining measures of dehydration and biomarkers that could be indicative of a wide range of internal disorders ranging from stress to kidney failure and even lung cancer.
Marcia Canto LabPrincipal Investigator:
Marcia Canto, M.D., M.H.S.
Research interests in the Marcia Canto Lab include pancreatic neoplasms, Barrett’s esophagus an...d endomicroscopy. We are also interested in the use of endoscopic ultrasound to identify early-stage pancreatic cancer and its precursors. view moreResearch Areas: endomicroscopy, Esophageal Disorders, pancreatic cancer, endoscopy, Barrett's esophagus